NANOG and cancer: Similarly, a recent study clearly demonstrated that inhibition of NF-kB reduces the expression of stem cell transcription factors SOX-2, NANOG, and Oct-4 in CSCs that present overexpression in several cancers, including breast, prostate, and oral squamous cell carcinoma [39].